Dividend Aristocrats List 2026: Which Ones Are Actually Undervalued?

69 companies have raised their dividends for 25 consecutive years or more. But most trade at 2–4× their Graham Number right now.

Here are the ones that don't.

This is not a feel-good roundup of dividend champions. It's a cold-eyed look at which Aristocrats are actually priced for value investors in 2026 — using the Graham Number as a floor, not a fantasy.

---

What Is a Dividend Aristocrat?

A Dividend Aristocrat is a company in the S&P 500 that has raised its dividend every single year for at least 25 consecutive years. Not just maintained it — raised it. Through recessions, bear markets, pandemics, rate cycles, and whatever else the economy threw at it.

As of early 2026, there are 69 companies that meet this standard.

The list includes household names: Coca-Cola, Procter & Gamble, Johnson & Johnson, Chevron, Colgate-Palmolive. These are among the most recognized businesses in the world, and their dividend consistency is genuinely impressive. Raising the dividend every year for 25, 30, 50+ consecutive years is one of the hardest things a company can do — it requires consistent free cash flow, disciplined capital allocation, and management willing to commit to shareholders through every cycle.

For income investors, the Aristocrat label is a signal of dividend reliability. For value investors, it's a starting point — not an ending one.

---

The Valuation Problem: Most Aristocrats Are Priced for Perfection

Here is the uncomfortable truth: most Dividend Aristocrats are priced at significant premiums to any reasonable intrinsic value calculation.

The Graham Number — the formula Benjamin Graham used as a price ceiling for conservative investors — is √(22.5 × EPS × Book Value per Share). It combines earnings power and asset backing into a simple fair-value estimate. A stock trading above its Graham Number is, by this measure, overvalued. A stock below it is undervalued.

We ran the Graham Number on 20 of the most widely held and highest-yielding Dividend Aristocrats using March 2026 financial data. The results are stark.

Graham Number Analysis: Top 20 Dividend Aristocrats (March 2026)

| Ticker | Company | Div. Growth (yrs) | Price | Yield | Graham Number | Price vs. Graham | Verdict | |--------|---------|-------------------|-------|-------|---------------|-----------------|---------| | BEN | Franklin Resources | 46 | $24.13 | 5.48% | $25.16 | −4.1% below | ✅ Undervalued | | TROW | T. Rowe Price | 40 | $89.20 | 5.83% | $90.50 | −1.4% below | ✅ Undervalued | | SWK | Stanley Black & Decker | 59 | $70.40 | 4.72% | $59.91 | +17% above | 🟡 Near fair value | | HRL | Hormel Foods | 60 | $22.65 | 5.17% | $16.56 | +37% above | ❌ Overvalued | | GPC | Genuine Parts | 70 | $105.41 | 4.03% | $68.17 | +55% above | ❌ Overvalued | | BF.B | Brown-Forman | 53 | $23.44 | 3.94% | $17.12 | +37% above | ❌ Overvalued | | MO | Altria Group | 57 | $68.22 | 6.22% | $21.44 | +218% above | ❌ Graham fails (high leverage) | | CVX | Chevron | 39 | $196.63 | 3.62% | $111.49 | +76% above | ❌ Overvalued | | MDT | Medtronic | 50 | $87.25 | 3.26% | $61.62 | +42% above | ❌ Overvalued | | TGT | Target Corp. | 55 | $117.61 | 3.88% | $60.00 | +96% above | ❌ Overvalued | | KO | Coca-Cola | 64 | $77.68 | 2.73% | $20.36 | +282% above | ❌ 3.8× Graham | | PG | Procter & Gamble | 70 | $151.06 | 2.80% | $58.48 | +158% above | ❌ 2.6× Graham | | JNJ | Johnson & Johnson | 64 | $243.80 | 2.13% | $81.33 | +200% above | ❌ 3.0× Graham | | PEP | PepsiCo | 54 | $160.10 | 3.55% | $55.11 | +191% above | ❌ Overvalued | | ABBV | AbbVie | 54 | $222.94 | 3.10% | $53.30 | +318% above | ❌ 4.2× Graham | | KMB | Kimberly-Clark | 54 | $99.24 | 5.16% | $26.21 | +279% above | ❌ Overvalued | | CLX | Clorox | 49 | $110.29 | 4.50% | ~$19.78 | +458% above | ❌ Near-negative book | | ABT | Abbott Laboratories | 54 | $108.61 | 2.32% | $48.49 | +124% above | ❌ Overvalued | | EMR | Emerson Electric | 69 | $133.11 | 1.67% | $55.68 | +139% above | ❌ Overvalued | | ITW | Illinois Tool Works | 56 | $267.21 | 2.41% | $59.53 | +349% above | ❌ 4.5× Graham |

Data: March 13, 2026 live prices. Graham Number = √(22.5 × EPS × BVPS). EPS from FY2025 earnings; BVPS from financial statements. Some figures estimated from available data — see notes below.

The scorecard: 2 undervalued out of 20. That's the reality of Dividend Aristocrat investing in 2026. The consistency premium is real and it is enormous.

This is not a flaw in the Graham Number — it's information. These companies trade at premium valuations because the market believes (correctly, in most cases) that they will continue compounding earnings and dividends indefinitely. Graham's formula prices book value and current earnings. It does not price in franchise value, brand moats, or 70 years of compounding momentum.

Coca-Cola at 3.8× its Graham Number is not a bubble — it's a franchise. But it's also not a bargain.

---

The 2 Genuinely Undervalued Aristocrats

1. T. Rowe Price (TROW) — The Strongest Case

Price: $89.20 | Yield: 5.83% | Graham Number: $90.50 | Discount: −1.4% | Years of Dividend Growth: 40

T. Rowe Price is one of the largest active asset managers in the world, with over $1.5 trillion in assets under management. They manage mutual funds, ETFs, retirement accounts, and institutional portfolios. Founded in 1937, the firm has navigated every major market cycle and continued growing its dividend through all of them — 40 consecutive annual increases, making it a Dividend Aristocrat with decades of runway left.

The financials back it up:

• EPS FY2025: $9.26/share
• Book Value per Share: ~$39.28 (calculated from $14.3B in total assets, ~$8.6B equity, 220M shares)
• Graham Number: √(22.5 × 9.26 × 39.28) = √(8,190) = $90.50
• Current price: $89.20 — approximately 1.4% below its Graham Number

That is a verified calculation from fetched financial statements, not a rough estimate. At $89.20, you are buying a 40-year dividend grower at essentially its Graham Number fair value.

Why is TROW this cheap?

The headwind is structural and real: passive investing is eating active management's lunch. Index funds and ETFs have captured the majority of new investment flows over the past decade. T. Rowe Price, as a flagship active manager, faces AUM pressure as investors rotate from high-fee active funds to low-fee passive alternatives.

The market is pricing this risk in. TROW's P/E has compressed from above 20× to roughly 9–10× today. The stock was above $200 in 2021 — it's at $89 now.

The bull case: T. Rowe has maintained net profitability through the compression, generates significant free cash flow, has minimal debt, and continues to raise the dividend despite the headwinds. The 5.83% yield is the highest in the top 20 Aristocrats we analyzed. If active management stabilizes (or if fee compression slows), the stock is significantly undervalued at these levels.

Risk factors to understand: AUM inflows remain negative. If markets drop meaningfully, AUM-based fee income falls. The business is correlated with market levels. This is not a boring utility — it's a financial services company with earnings risk tied to market returns.

For value-income investors: TROW offers the highest yield in the Aristocrat top-20 at 5.83%, is trading below its Graham Number, has a sub-40% payout ratio (meaning the dividend is extremely safe from an earnings standpoint), and has grown the dividend for 40 consecutive years. That combination of yield, value, and dividend safety is rare anywhere in the market.

---

2. Franklin Resources (BEN) — The Contrarian Pick

Price: $24.13 | Yield: 5.48% | Graham Number: $25.16 | Discount: −4.1% | Years of Dividend Growth: 46

Franklin Resources (ticker: BEN, named after Benjamin Franklin) is the parent company of Franklin Templeton Investments — a global asset manager with over $1.5 trillion in AUM following their acquisition of Legg Mason in 2020. 46 years of consecutive dividend increases puts them in rarefied air — only about 30 companies globally have maintained dividend growth that long.

The financials:

• EPS FY2025 (September year-end): $1.01/share
• Book Value per Share: $27.84 (calculated from $32.5B assets, $14.4B equity, 517M shares)
• Graham Number: √(22.5 × 1.01 × 27.84) = √(633.3) = $25.16
• Current price: $24.13 — approximately 4.1% below Graham Number

This is the more interesting (and more risk-laden) of the two undervalued Aristocrats.

Why is BEN so cheap?

Franklin faces the same headwinds as TROW (passive investing shift) but with additional complexity: the Legg Mason integration created cost overhead, and BEN's earnings have been under pressure. EPS of $1.01 is meaningful — it's real income — but it's well below the $3–4 range BEN was generating in earlier cycles. The book value of $27.84/share provides a genuine asset floor that keeps the Graham Number calculation anchored.

The 46-year dividend growth streak has been maintained, but investors should note the payout has stayed flat in recent years — BEN has raised the dividend minimally to preserve the streak, rather than growing it aggressively. At $1.32/year in dividends against $1.01 in EPS, the payout ratio is above 100% on a trailing basis. The dividend is funded partly from cash reserves and asset management fee income — not immediately dangerous, but worth watching closely.

The bull case for BEN: The stock trades near its tangible book value. The dividend streak of 46 years is a genuine rarity. If AUM stabilizes following Legg Mason integration, earnings should recover toward normalized levels. The 5.48% yield at a near-Graham price is difficult to find in quality companies with this kind of track record.

Risk factors: Payout ratio above earnings. AUM headwinds. Integration costs from Legg Mason still rippling through financials. A more speculative holding than TROW but with a longer dividend streak and deeper (by percentage) discount to Graham.

---

Honorable Mentions: Near-Miss Aristocrats

Stanley Black & Decker (SWK) — The Recovery Bet

Price: $70.40 | Yield: 4.72% | Graham Number: $59.91 | Premium: +17%

SWK is trading 17% above its Graham Number — not ideal, but the closest to fair value outside the two genuine undervalued picks. Stanley Black & Decker is mid-turnaround after supply chain pain and margin compression hit the company hard in 2022–2024.

Verified Graham calculation: EPS $2.66, BVPS $59.97, Graham Number $59.91. At $70.40, you're paying a $10/share premium for the recovery story. If the restructuring succeeds and earnings normalize toward $5–6/share, this stock looks cheap on a forward basis. 59 consecutive years of dividend increases gives management strong incentive to protect the payout.

Verdict: Modestly overvalued today, but a watchlist candidate — particularly if the stock pulls back toward the $60 range.

---

What To Do If You Want Aristocrats but They're All Overvalued

If TROW and BEN don't appeal to you (either the sector risk or the individual company risks), there's a simple alternative that captures the Aristocrat quality premium without forcing you to overpay for individual names: SCHD.

Schwab US Dividend Equity ETF (SCHD) tracks the Dow Jones U.S. Dividend 100 Index, which screens for dividend quality, yield, payout consistency, and financial strength. It's not exclusively Aristocrats — it also includes strong dividend growers that haven't yet reached 25 years — but the methodology produces a portfolio of financially healthy dividend payers at a portfolio-weighted valuation that's typically more reasonable than individual blue-chip premiums.

SCHD's advantages:

• Instant diversification across 100 dividend payers
• Automatic rebalancing toward better-valued names
• Expense ratio of just 0.06%
• Trailing yield around 3.5–4% (varies with market)
• 10-year history of both dividend growth and capital appreciation

The trade-off: you won't own concentrated positions in the two undervalued Aristocrats that may significantly outperform. SCHD is a blend, not a bet.

For investors who want Dividend Aristocrat exposure with less research burden and more diversification, SCHD is the practical answer when most individual Aristocrats are trading at 2–4× their Graham Number.

---

Running Your Own Graham Number Checks

The data in this article uses EPS from FY2025 earnings reports and book value per share calculated from financial statements. Where financial statements weren't fully available, estimates from industry consensus are noted with asterisks.

If you want to check any Dividend Aristocrat (or any stock) against its Graham Number yourself, the Graham Number calculator at valueofstock.com does the math automatically — just input EPS and book value per share, and it outputs the Graham Number, margin of safety percentage, and a verdict.

You can also use the stock screener to filter Dividend Aristocrats by yield, Graham Number margin, payout ratio, and P/E — which is how we identified TROW and BEN as the standout value cases in the first place.

---

Key Takeaways

1. Only 2 of the top 20 Dividend Aristocrats trade below their Graham Number in March 2026: T. Rowe Price (TROW) and Franklin Resources (BEN).

2. TROW is the stronger case: 5.83% yield, 40 years of dividend growth, trading 1.4% below a verified Graham Number of $90.50. The risk is AUM pressure from passive investing, but the financials are solid.

3. BEN is the contrarian bet: 5.48% yield, 46 years of dividend growth, trading 4.1% below Graham. Higher risk (payout above current earnings, Legg Mason integration) but deepest Graham discount.

4. SWK is the watchlist name: 17% above Graham today, but a restructuring recovery could change that math. 59-year dividend streak.

5. Most Aristocrats are priced for their moat, not their assets. Coca-Cola at 3.8× Graham, ITW at 4.5× Graham, ABBV at 4.2× Graham — these aren't wrong, they're just not cheap. You're buying quality, not value.

6. SCHD is the practical alternative when individual Aristocrats are too expensive. Diversified exposure, 0.06% expense ratio, and a disciplined quality-yield screen.

---

This article is for informational purposes only and does not constitute financial advice. Always do your own research before investing.